The "portait" of hereditary breast cancer

被引:38
作者
Lacroix, M [1 ]
Leclercq, G [1 ]
机构
[1] Free Univ Brussels, Inst Jules Bordet, Lab Jean Claude Heuson Cancerol Mammaire, B-1000 Brussels, Belgium
关键词
basal; BRCA1; BRCA2; BRCAx; estrogen receptor; genotype; hereditary cancer; luminal; phenotype; p53;
D O I
10.1007/s10549-004-2172-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Five to ten per cent of all breast carcinomas are of hereditary origin. Many of them have been associated to mutations in the BRCA1 and BRCA2 susceptibility genes. No "BRCA3" gene has been found to account for the non-BRCA1/BRCA2 breast cancer (BRCAx) families, and BRCAx tumors are increasingly believed to originate from multiple distinct genetic events. Phenotype studies have questioned the existence of specific "portraits" among hereditary breast carcinomas (HBC). They have shown that most BRCA1 tumors have a "basal (epithelial)-like" aspect, while BRCA2 and BRCAx HBC are more heterogeneous. HBC have also been submitted to genetic analyses, notably with the objective of resolving the heterogeneity of BRCAx lesions. The present review aims to summarize recent data on BRCA1, BRCA2, and BRCAx HBC, including hypotheses on the origin of BRCA1 tumors and their paradoxical relations to estrogen-sensitivity.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 79 条
[1]   Epigenetic gene regulation by noncoding RNAs [J].
Andersen, AA ;
Panning, B .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (03) :281-289
[2]   Is male breast cancer similar or different than female breast cancer? [J].
Anderson, WF ;
Althuis, MD ;
Brinton, LA ;
Devesa, SS .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) :77-86
[3]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[4]   Androgen pathway dysregulation in BRCA1-mutated breast tumors [J].
Berns, EMJJ ;
Dirkzwager-Kiel, MJM ;
Kuenen-Boumeester, V ;
Timmermans, M ;
Verhoog, LC ;
van den Ouweland, AMW ;
Meijer-Heijboer, H ;
Klijn, JGM ;
van der Kwast, TH .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (01) :121-127
[5]  
Bonadona V, 2003, B CANCER, V90, P587
[6]   Molecular and pathological characterization of inherited breast cancer [J].
Borg, Å .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (05) :375-385
[7]   Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice [J].
Brodie, SG ;
Xu, XL ;
Qiao, WH ;
Li, WM ;
Cao, L ;
Deng, CX .
ONCOGENE, 2001, 20 (51) :7514-7523
[8]  
Carter RF, 2001, CLIN INVEST MED, V24, P147
[9]  
Chan HM, 2001, J CELL SCI, V114, P2363
[10]  
Chen YM, 1996, CANCER RES, V56, P3168